Myovant Sciences Ltd. Business Operations Contracts & Agreements
20 Contracts & Agreements
- Cooperation Agreements (2 contracts)
- Indemnification Agreements (1)
- MOUs (1)
- Sales Agreements (1)
- Services Agreements (9)
- Supply Agreements (5)
- Voting Agreements (1)
- Amendment No. 4 to Market Access Services Agreement by and between Sunovion Pharmaceuticals Inc. and Myovant Sciences GmbH, dated August 9, 2022 (Filed With SEC on October 26, 2022)
- Amendment No. 3 to Market Access Services Agreement by and between Sunovion Pharmaceuticals Inc. and Myovant Sciences GmbH, dated March 15, 2021 (Filed With SEC on October 26, 2022)
- Amended and Restated Manufacturing & Services Agreement by and between Excella GmbH & Co. KG and Myovant Sciences GmbH, dated April 2, 2021 (Filed With SEC on October 26, 2022)
- Voting and Support Agreement, dated as of October 23, 2022, between Myovant Sciences Ltd. and Sumitovant Biopharma Ltd (Filed With SEC on October 24, 2022)
- Letter of Understanding between Myovant Sciences, Inc. and Matthew Lang (Filed With SEC on July 27, 2022)
- Amendment No.2 to Market Access Services Agreement, dated as of January 25, 2021, by and between Sunovion Pharmaceuticals Inc. and Myovant Sciences GmbH (Filed With SEC on May 11, 2021)
- Commercial Manufacturing & Supply Agreement, effective as of May 30, 2018, by and between Myovant Sciences GmbH and Takeda Pharmaceutical Company Limited (Filed With SEC on May 11, 2021)
- Amendment No.1 to Market Access Services Agreement, dated as of (Filed With SEC on February 11, 2021)
- Commercial Manufacturing and Supply Agreement, dated April 4, 2019, by and between Excella GmbH & Co. KG and Myovant Sciences GmbH (Filed With SEC on November 12, 2020)
- Market Access Services Agreement, dated as of August 1, 2020, by and between Sunovion Pharmaceuticals Inc. and Myovant Sciences GmbH (Filed With SEC on November 12, 2020)
- Amendment No.1 to Information Sharing and Cooperation Agreement, dated as of May 24, 2019, by and between Roivant Sciences Ltd. and the Registrant (Filed With SEC on May 24, 2019)
- Commercial Manufacturing & Supply Agreement, effective as of May 30, 2018, by and between Myovant Sciences GmbH and Takeda Pharmaceutical Company Limited (Filed With SEC on August 7, 2018)
- Sales Agreement, dated as of April 2, 2018, between Myovant Sciences Ltd. and Cowen and Company, LLC (Filed With SEC on April 3, 2018)
- SERVICES AGREEMENT (Filed With SEC on February 13, 2017)
- AMENDED AND RESTATED SERVICES AGREEMENT (Filed With SEC on February 13, 2017)
- AGREEMENT FOR THEMANUFACTURE & SUPPLY OF CLINICAL TRIAL MATERIAL BY AND BETWEEN TAKEDA PHARMACEUTICAL COMPANY LIMITED, AND MYOVANT SCIENCESLTD. DATE: JUNE 7, 2016 (Filed With SEC on October 20, 2016)
- INFORMATIONSHARING AND COOPERATION AGREEMENT (Filed With SEC on September 30, 2016)
- SERVICESAGREEMENT (Filed With SEC on September 30, 2016)
- MYOVANT SCIENCES LTD. Indemnification Agreement (Filed With SEC on September 30, 2016)
- AGREEMENT FOR THEMANUFACTURE & SUPPLY OF CLINICAL TRIAL MATERIAL BY AND BETWEEN TAKEDA PHARMACEUTICAL COMPANY LIMITED, AND MYOVANT SCIENCESLTD. DATE: JUNE 7, 2016 (Filed With SEC on September 30, 2016)
